Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2025 Aug 22:105:adv44220.
doi: 10.2340/actadv.v105.44220.

European S2k Guideline on Chronic Pruritus

Elke Weisshaar  1 , Simon Müller  2 , Jacek C Szepietowski  3 , Florence Dalgard  4 , Simone Garcovich  5 , Jörg Kupfer  6 , Ana Gimenez-Arnau  7 , Julien Lambert  8 , Thomas Mettang  9 , Laurent Misery  10 , Ekin Savk  11 , Erwin Tschachler  12 , Joanna Wallengren  12 , Sonja Ständer  13
Affiliations
Practice Guideline

European S2k Guideline on Chronic Pruritus

Elke Weisshaar et al. Acta Derm Venereol. .

Abstract

Pruritus is a frequent symptom in medicine. Population-based studies show that one in five persons in the general population has suffered from chronic pruritus (CP) at least once in their lifetime, with a 12-month incidence of 7%. CP, which can affect all age groups, is associated with numerous, often interdisciplinary medical conditions. It needs a precise diagnostic work-up to identify causes and relevant comorbidities. Management of CP comprises treatment of the underlying disease as well as topical and systemic therapies. Treating CP needs to be targeted, multimodal and performed in a step-wise procedure requiring an interdisciplinary approach. In recent years, novel on-label therapies have been approved for CP, including therapies for chronic prurigo and cholestatic pruritus. We present the updated European guideline on chronic pruritus by a team of European pruritus experts from different disciplines.

PubMed Disclaimer

Conflict of interest statement

see table enclosed

Figures

Fig. 1
Fig. 1
Diagnostic algorithm. See abbreviations and explanations (page 2).
See this image and copyright information in PMC

References

    1. Abella, B. S., W. E. Berger, M. S. Blaiss, I. G. Stiell, J. P. Herres, J. J. Moellman, S. Suner, A. Kessler, H. A. Klausner, J. M. Caterino and J. Du (2020). “Intravenous Cetirizine Versus Intravenous Diphenhydramine for the Treatment of Acute Urticaria: A Phase III Randomized Controlled Noninferiority Trial.” Ann Emerg Med 76(4): 489–500. 10.1016/j.annemergmed.2020.05.025 - DOI - PubMed
    1. Aboeldahab, S., F. Khalil and R. Ezz Eldawla (2021). “Clinical and Laboratory Characteristics of Elderly Patients with Pruritus.” Clin Cosmet Investig Dermatol 14: 1009–1015. 10.2147/CCID.S322527 - DOI - PMC - PubMed
    1. Aboeldahab, S. S., F. J. Khalil and R. E. Eldawla (2021). “Clinical and Laboratory Characteristics of Elderly Patients with Pruritus.” Clin Cosmet Investig Dermatol 14: 1009–1015. 10.2147/CCID.S322527 - DOI - PMC - PubMed
    1. Acevedo Ribo, M., J. M. Moreno Planas, C. Sanz Moreno, E. E. Rubio Gonzalez, E. Rubio Gonzalez, E. Boullosa Grana, V. Sanchez-Turrion, D. Sanz Guajardo and V. Cuervas-Mons (2005). “Therapy of intractable pruritus with MARS.” Transplant Proc 37(3): 1480–1481. 10.1016/j.transproceed.2005.02.002 - DOI - PubMed
    1. Ada, S., D. Seckin, I. Budakoglu and F. N. Ozdemir (2005). “Treatment of uremic pruritus with narrowband ultraviolet B phototherapy: an open pilot study.” J Am Acad Dermatol 53(1): 149–151. 10.1016/j.jaad.2004.12.052 - DOI - PubMed

Publication types

LinkOut - more resources